{"transactions":[{"id":751415,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-06-03T21:28:29.000Z","date":"2026-06-01","kind":"grant","planned":false,"acquired":true,"shares":40412,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Scheduled to vest in four equal quarterly installments."}],"balance_after":40412,"derivative":{"exercise_price":5.84,"expiration_date":"2036-06-01","underlying":"Voting Common Shares","underlying_shares":40412},"source":{"system":"sec-edgar","filing":"0001759822-26-000004","document":"form4-06032026_090625.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000175982226000004/form4-06032026_090625.xml","form_type":"4"}},{"id":946161,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-06T22:24:08.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":6175,"price":8.42,"value":51993.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan, in lieu of cash retainer fees in the aggregate amount of $52,000. The deferred stock units are scheduled to vest in four nearly equal installments on each of March 31, June 30, September 30, and December 31, 2026."}],"balance_after":398587,"source":{"system":"sec-edgar","filing":"0001759822-26-000002","document":"form4-01062026_100105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000175982226000002/form4-01062026_100105.xml","form_type":"4"}},{"id":1124618,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true}}],"security":"Stock Option (right to buy)","published_at":"2025-06-03T20:15:32.000Z","date":"2025-06-01","kind":"grant","planned":false,"acquired":true,"shares":32162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":32162,"derivative":{"exercise_price":4.11,"expiration_date":"2035-05-31","underlying":"Common Shares","underlying_shares":32162},"source":{"system":"sec-edgar","filing":"0001437749-25-019289","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000143774925019289/rdgdoc.xml","form_type":"4"}},{"id":1263545,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-18T21:25:44.000Z","date":"2025-02-13","kind":"exercise","planned":false,"acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option has fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.65,"expiration_date":"2026-11-28","underlying":"Common Shares","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001235802-25-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000009/primary_doc.xml","form_type":"4"}},{"id":1263544,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-02-18T21:25:44.000Z","date":"2025-02-13","kind":"exercise","planned":false,"acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option has fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.11,"expiration_date":"2025-12-01","underlying":"Common Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001235802-25-000009","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000009/primary_doc.xml","form_type":"4"}},{"id":1263543,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2025-02-18T21:25:44.000Z","date":"2025-02-13","kind":"exercise","planned":false,"acquired":true,"shares":5000,"price":3.65,"value":18250.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 95,016 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 128,360 voting common shares held by Michael Giuffre individually."}],"balance_after":392412,"source":{"system":"sec-edgar","filing":"0001235802-25-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000009/primary_doc.xml","form_type":"4"}},{"id":1263542,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2025-02-18T21:25:44.000Z","date":"2025-02-13","kind":"exercise","planned":false,"acquired":true,"shares":12000,"price":2.11,"value":25320.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 95,016 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 128,360 voting common shares held by Michael Giuffre individually."}],"balance_after":387412,"source":{"system":"sec-edgar","filing":"0001235802-25-000009","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000009/primary_doc.xml","form_type":"4"}},{"id":1314219,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2025-01-03T21:36:36.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":10861,"price":5.34,"value":57997.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. Amended and Restated 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $58,000.  The deferred stock units will vest in four nearly equal installments on each of March 31, 2025, June 30, 2025, September 30, 2025 and December 31, 2025."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 95,016 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, as amended from time to time, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 111,360 voting common shares held by Michael Giuffre individually."}],"balance_after":375412,"source":{"system":"sec-edgar","filing":"0001235802-25-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580225000004/primary_doc.xml","form_type":"4"}},{"id":1494971,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-06-03T20:02:39.000Z","date":"2024-06-01","kind":"grant","planned":false,"acquired":true,"shares":28472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":28472,"derivative":{"exercise_price":2.9,"expiration_date":"2034-05-31","underlying":"Common Shares","underlying_shares":28472},"source":{"system":"sec-edgar","filing":"0001235802-24-000044","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000044/primary_doc.xml","form_type":"4"}},{"id":1696364,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2024-01-02T21:30:43.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":19196,"price":2.8,"value":53748.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $53,750."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 84,155 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 111,360 voting common shares held by Michael Giuffre individually."}],"balance_after":364551,"source":{"system":"sec-edgar","filing":"0001235802-24-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580224000001/primary_doc.xml","form_type":"4"}},{"id":1844121,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-06-26T20:42:45.000Z","date":"2023-06-23","kind":"gift","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":345355,"source":{"system":"sec-edgar","filing":"0001235802-23-000073","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000073/primary_doc.xml","form_type":"4"}},{"id":1844120,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-06-26T20:42:45.000Z","date":"2023-06-23","kind":"purchase","planned":false,"acquired":true,"shares":65000,"price":3.91,"value":254150.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 64,959 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually."}],"balance_after":360355,"source":{"system":"sec-edgar","filing":"0001235802-23-000073","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000073/primary_doc.xml","form_type":"4"}},{"id":1869419,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-06-02T20:02:20.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":16968,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":16968,"derivative":{"exercise_price":2.73,"expiration_date":"2033-05-31","underlying":"Common Shares","underlying_shares":16968},"source":{"system":"sec-edgar","filing":"0001235802-23-000056","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000056/primary_doc.xml","form_type":"4"}},{"id":2072460,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2023-01-03T21:43:43.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":35130,"price":1.53,"value":53748.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $53,750."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 64,959 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually."}],"balance_after":295355,"source":{"system":"sec-edgar","filing":"0001235802-23-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580223000004/primary_doc.xml","form_type":"4"}},{"id":2089549,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2022-12-12T21:34:02.000Z","date":"2022-12-09","kind":"purchase","acquired":true,"shares":37079,"price":1.43,"value":53022.97,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $1.41 to $1.44, inclusive.  The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 29,829 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually."}],"balance_after":260225,"source":{"system":"sec-edgar","filing":"0001235802-22-000135","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580222000135/primary_doc.xml","form_type":"4"}},{"id":2089548,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2022-12-12T21:34:02.000Z","date":"2022-12-08","kind":"purchase","acquired":true,"shares":20000,"price":1.4,"value":28000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 29,829 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 164,890 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually."}],"balance_after":223146,"source":{"system":"sec-edgar","filing":"0001235802-22-000135","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580222000135/primary_doc.xml","form_type":"4"}},{"id":2092124,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2022-12-08T21:55:07.000Z","date":"2022-12-07","kind":"purchase","acquired":true,"shares":22574,"price":1.4,"value":31603.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $1.36 to $1.40, inclusive.  The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (2) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 29,829 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 107,811 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually."}],"balance_after":203146,"source":{"system":"sec-edgar","filing":"0001235802-22-000134","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580222000134/primary_doc.xml","form_type":"4"}},{"id":2092123,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2022-12-08T21:55:07.000Z","date":"2022-12-06","kind":"purchase","acquired":true,"shares":2300,"price":1.35,"value":3105.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 29,829 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 107,811 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually."}],"balance_after":180572,"source":{"system":"sec-edgar","filing":"0001235802-22-000134","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580222000134/primary_doc.xml","form_type":"4"}},{"id":2095901,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2022-12-05T21:08:29.000Z","date":"2022-12-01","kind":"purchase","acquired":true,"shares":819,"price":1.19,"value":974.61,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 29,829 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 82,937 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually."}],"balance_after":178272,"source":{"system":"sec-edgar","filing":"0001235802-22-000129","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580222000129/primary_doc.xml","form_type":"4"}},{"id":2099952,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2022-12-01T22:11:39.000Z","date":"2022-12-01","kind":"purchase","acquired":true,"shares":46133,"price":1.2,"value":55359.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.20, inclusive.  The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (3) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 29,829 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 82,118 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually."}],"balance_after":177453,"source":{"system":"sec-edgar","filing":"0001235802-22-000128","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580222000128/primary_doc.xml","form_type":"4"}},{"id":2099951,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2022-12-01T22:11:39.000Z","date":"2022-11-30","kind":"purchase","acquired":true,"shares":2970,"price":1.19,"value":3534.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.19, inclusive.  The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 29,829 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 82,118 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually."}],"balance_after":131320,"source":{"system":"sec-edgar","filing":"0001235802-22-000128","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580222000128/primary_doc.xml","form_type":"4"}},{"id":2099950,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2022-12-01T22:11:39.000Z","date":"2022-11-29","kind":"purchase","acquired":true,"shares":18125,"price":1.19,"value":21568.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $1.18 to $1.19, inclusive.  The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 29,829 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 82,118 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually."}],"balance_after":128350,"source":{"system":"sec-edgar","filing":"0001235802-22-000128","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580222000128/primary_doc.xml","form_type":"4"}},{"id":2247264,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-02T20:51:01.000Z","date":"2022-06-01","kind":"grant","acquired":true,"shares":13222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":13222,"derivative":{"exercise_price":2.45,"expiration_date":"2032-05-31","underlying":"Common Shares","underlying_shares":13222},"source":{"system":"sec-edgar","filing":"0001235802-22-000073","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580222000073/primary_doc.xml","form_type":"4"}},{"id":2454049,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2022-01-03T21:09:49.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":15026,"price":3.58,"value":53793.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $53,750."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Amount reflects the cancellation of 422 shares underlying deferred share units granted in lieu of Board committee retainers due to a change in Board committee memberships."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 29,829 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 14,890 voting common shares held by Michael Giuffre and his wife jointly and 61,360 voting common shares held by Michael Giuffre individually."}],"balance_after":110225,"source":{"system":"sec-edgar","filing":"0001235802-22-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580222000001/primary_doc.xml","form_type":"4"}},{"id":2631890,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option  (right to buy)","published_at":"2021-07-16T20:52:09.000Z","date":"2021-07-15","kind":"grant","acquired":true,"shares":9393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":9393,"derivative":{"exercise_price":3.64,"expiration_date":"2031-07-14","underlying":"Common Shares","underlying_shares":9393},"source":{"system":"sec-edgar","filing":"0001235802-21-000082","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580221000082/primary_doc.xml","form_type":"4"}},{"id":2925379,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2021-01-04T21:33:19.000Z","date":"2021-01-01","kind":"grant","acquired":true,"shares":7441,"price":8.23,"value":61239.43,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $61,250."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 15,225 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 36,498 voting common shares held by Michael Giuffre and his wife jointly and 60,160 voting common shares held by Michael Giuffre individually."}],"balance_after":116029,"source":{"system":"sec-edgar","filing":"0001235802-21-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580221000003/primary_doc.xml","form_type":"4"}},{"id":2969724,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2020-11-23T21:22:20.000Z","date":"2020-11-20","kind":"purchase","acquired":true,"shares":15000,"price":4.2608,"value":63912.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $4.249 to $4.283, inclusive.  The reporting person undertakes to provide to DiaMedica Therapeutics Inc., any security holder of DiaMedica Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 7,784 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan, 36,498 voting common shares held by Michael Giuffre and his wife jointly and 60,160 voting common shares held by Michael Giuffre individually."}],"balance_after":108588,"source":{"system":"sec-edgar","filing":"0001235802-20-000138","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580220000138/primary_doc.xml","form_type":"4"}},{"id":3126746,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-02T20:59:52.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":13306,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":13306,"derivative":{"exercise_price":4.64,"expiration_date":"2030-05-31","underlying":"Common Shares","underlying_shares":13306},"source":{"system":"sec-edgar","filing":"0001235802-20-000051","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580220000051/primary_doc.xml","form_type":"4"}},{"id":3126745,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2020-06-02T20:59:52.000Z","date":"2020-06-01","kind":"grant","acquired":true,"shares":7784,"price":4.59,"value":35728.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares are issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan in lieu of cash retainer fees in the aggregate amount of $35,729."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 36,498 voting common shares held by Michael Giuffre and his wife jointly and 45,160 voting common shares held by Michael Giuffre individually."}],"balance_after":93588,"source":{"system":"sec-edgar","filing":"0001235802-20-000051","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580220000051/primary_doc.xml","form_type":"4"}},{"id":3477981,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-26T20:24:57.000Z","date":"2019-06-24","kind":"grant","acquired":true,"shares":12950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in four nearly equal quarterly installments over one year."}],"balance_after":12950,"derivative":{"exercise_price":4.6,"expiration_date":"2029-06-23","underlying":"Common Shares","underlying_shares":12950},"source":{"system":"sec-edgar","filing":"0001235802-19-000061","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580219000061/primary_doc.xml","form_type":"4"}},{"id":3735338,"issuer":{"id":5813,"kind":"organization","name":"DiaMedica Therapeutics Inc."},"owners":[{"id":41699,"kind":"person","name":"Giuffre Randall Michael","position":1,"cik":"0001759822","reported_name":"Giuffre Randall Michael","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Voting Common Shares, no par value per share","published_at":"2018-12-11T21:17:38.000Z","date":"2018-12-11","kind":"purchase","acquired":true,"shares":11250,"price":4,"value":45000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 4,146 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan, 36,498 voting common shares held by Michael Giuffre and his wife jointly and 45,160 voting common shares held by Michael Giuffre individually."}],"balance_after":85804,"source":{"system":"sec-edgar","filing":"0001235802-18-000179","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1401040/000123580218000179/primary_doc.xml","form_type":"4"}}]}